Avanza Fonder AB Lowers Stake in Cardinal Health, Inc. $CAH

Avanza Fonder AB cut its stake in Cardinal Health, Inc. (NYSE:CAH) by 72.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,534 shares of the company’s stock after selling 17,480 shares during the period. Avanza Fonder AB’s holdings in Cardinal Health were worth $1,343,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Latitude Advisors LLC grew its stake in Cardinal Health by 2.1% in the 3rd quarter. Latitude Advisors LLC now owns 2,598 shares of the company’s stock worth $408,000 after acquiring an additional 53 shares in the last quarter. MFA Wealth Services increased its position in shares of Cardinal Health by 2.3% during the third quarter. MFA Wealth Services now owns 2,491 shares of the company’s stock worth $391,000 after acquiring an additional 55 shares during the period. Sound View Wealth Advisors Group LLC raised its stake in shares of Cardinal Health by 2.8% during the fourth quarter. Sound View Wealth Advisors Group LLC now owns 2,145 shares of the company’s stock valued at $441,000 after acquiring an additional 58 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Cardinal Health by 3.5% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,725 shares of the company’s stock valued at $354,000 after purchasing an additional 59 shares during the period. Finally, Vertex Planning Partners LLC boosted its holdings in shares of Cardinal Health by 3.7% in the third quarter. Vertex Planning Partners LLC now owns 1,702 shares of the company’s stock valued at $267,000 after purchasing an additional 60 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have commented on CAH shares. Mizuho raised their price objective on Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a report on Friday, February 6th. Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, January 21st. Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 21st. Morgan Stanley set a $255.00 price objective on Cardinal Health in a report on Friday, February 6th. Finally, Argus upped their price objective on shares of Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. One analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $245.67.

Cardinal Health Stock Performance

Cardinal Health stock opened at $207.22 on Wednesday. The stock has a market cap of $48.76 billion, a PE ratio of 29.82, a price-to-earnings-growth ratio of 1.33 and a beta of 0.65. The stock has a 50-day moving average of $217.68 and a two-hundred day moving average of $195.54. Cardinal Health, Inc. has a one year low of $120.72 and a one year high of $233.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.31 by $0.32. The firm had revenue of $65.63 billion for the quarter, compared to the consensus estimate of $64.88 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.93 earnings per share. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be paid a dividend of $0.5107 per share. The ex-dividend date is Wednesday, April 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. Cardinal Health’s dividend payout ratio is presently 29.35%.

Key Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Improved specialty pharma mix cited as a driver of recent upside—media coverage shows investors rewarded better product mix and margin expansion trends. Cardinal Health (CAH) Surged Following Improved Specialty Mix in Pharma
• Positive Sentiment: Analysts and comparative pieces highlight CAH’s stronger earnings growth and margin improvement versus peers, supporting a bullish view on the turnaround. Cardinal Health vs. McKesson: Which Healthcare Giant Is the Smarter Bet?
• Positive Sentiment: Street sentiment is supportive: aggregated analyst commentary and an average “Moderate Buy” tone help underpin investor confidence. Cardinal Health, Inc. (NYSE:CAH) Given Average Rating of “Moderate Buy” by Analysts
• Neutral Sentiment: GLP‑1 drug distribution is contributing meaningful revenue growth but appears to be a mixed margin story—higher volumes lift top line but benefits to profitability are uneven. Are GLP-1 Drugs Becoming a Meaningful Revenue Driver for CAH Stock?
• Neutral Sentiment: Corporate governance update: a new independent board chair (Patricia A. Hemingway Hall) was appointed—governance continuity, not a major operational catalyst. Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair
• Neutral Sentiment: Cardinal confirmed its Q3 FY2026 report date (April 30) and will webcast results—an upcoming earnings release that could amplify volatility around guidance and margin commentary. Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2026 on April 30
• Neutral Sentiment: Notes on index/ETF dynamics: coverage highlights CAH’s positioning in Russell 1000/ETF flows which can influence demand but is not an immediate earnings driver. Cardinal Health (NYSE:CAH) Strengthens Global Network For Russell 1000 Etf Watchers
• Negative Sentiment: Short interest rose sharply (~21% month-over-month to ~6.05M shares, ~2.6% of float), increasing the potential for pressure or volatility if sentiment shifts; days-to-cover sits around 3.1 days. (Data entry 3/24/2026)

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.